Acarbose Tablets 50 Mg

Acarbose Tablets 50 Mg

Acarbose Tablets 50 Mg is an oral anti-diabetic medication used to manage blood sugar levels in patients with type 2 diabetes mellitus. It belongs to the class of alpha-glucosidase inhibitors, which help control post-meal glucose spikes by slowing carbohydrate digestion. This strength is typically prescribed when a lower dose is not sufficient for glycemic control. It is commonly used along with diet and lifestyle modifications for effective diabetes management. In treatment plans, lower doses like Acarbose Tablets 25 Mg are often used initially, while combination therapies such as Diabetes – Janumet Tablets 50/500 Mg may be prescribed for improved blood sugar control.

Mechanism of Action

Enzyme Inhibition

Acarbose works by inhibiting alpha-glucosidase enzymes in the intestine, delaying the breakdown of carbohydrates into glucose.

Post-Meal Sugar Control

This leads to a slower and more controlled rise in blood sugar levels after meals. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Acarbose Information.

Medical Uses

Acarbose Tablets 50 Mg is used for:

• Type 2 diabetes mellitus
• Postprandial blood sugar control
• Combination therapy with other antidiabetic medications

It is commonly included in comprehensive diabetes care plans.

Dosage and Administration

Acarbose Tablets 50 Mg is usually taken with the first bite of each main meal, as prescribed by a healthcare provider. The dosage may be adjusted based on blood sugar levels and patient response. In clinical practice, Acarbose Tablets 25 Mg may be used as a starting dose, while Diabetes – Janumet Tablets 50/500 Mg is used in combination therapy for enhanced glycemic control.

Clinical Effectiveness

Clinical studies show that acarbose effectively reduces post-meal glucose spikes and improves overall blood sugar management when used consistently.

Safety and Side Effects

Common Side Effects

• Flatulence
• Abdominal discomfort
• Diarrhea

Serious Risks

• Liver enzyme elevation (rare)
• Severe gastrointestinal symptoms

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Acarbose Information.

Contraindications and Precautions

Acarbose Tablets 50 Mg should not be used in:

• Patients with inflammatory bowel disease
• Severe kidney or liver disease
• Intestinal obstruction

Consult a healthcare provider before use.

Drug Interactions

Acarbose may interact with other antidiabetic medications, increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medications they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs